Affimed Presents Poster at AACR Highlighting Progress Toward Novel EGFR-targeting Therapy

World News: . []

Despite several marketed agents such as cetuximab and tyrosine kinase inhibitors there is a significant medical need for a novel approach to treat EGFR tumors by widening the therapeutic window and addressing current treatment resistance To meet the nee...

More news and information about Affimed N.V.

Published By:

Globe Newswire: 19:01 GMT Monday 16th April 2018

Published: .

Search for other references to "affimed" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us